Literature DB >> 6448588

Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach.

O Salvatierra, F Vincenti, W Amend, D Potter, Y Iwaki, G Opelz, P Terasaki, R Duca, K Cochrum, D Hanes, R J Stoney, N J Feduska.   

Abstract

In order to select MLC incompatible one-haplotype related donor-recipient pairs that would achieve better graft survival and in an effort to alter the recipient immune response, 45 patients received three fresh blood transfuions from their prospective kidney donors. Recipient sensitization was evaluated by cross-match testing weekly sera obtained during and after the blood transfusions against donor T- and B-lymphocytes at 5 C (cold) and 37 C (warm). Thirteen (29%) of the 45 potential related recipients developed a positive warm T-cell cross-match or a persistent warm B-cell cross-match to their blood donor and related transplantation was not performed. Thirty-two (71%) patients had an appropriate negative cross-match to their blood donor. Thirty of these patients subsequently received kidneys from their blood donor. Ninety-seven per cent of the kidneys are functioning from one to 25 months with a single graft failure due to a patient discontinuing immunosuppressive medication. In addition to the excellent graft survival there was an unusually low incidence of rejection episodes in the recipients of kidneys from their blood donor so that the posttransplant course paralleled that of HLA-identical siblings. This approach may have future application with two-haplotype mismatched donor-recipient pairs, both related and unrelated.

Entities:  

Mesh:

Year:  1980        PMID: 6448588      PMCID: PMC1347002          DOI: 10.1097/00000658-198010000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

1.  MLC incompatibility index for donor--recipient matching.

Authors:  D T Uehling; J L Hussey; F O Belzer; C Kan; F H Bach
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

2.  The effect of donor strain blood pretreatment on renal allograft rejection in rats.

Authors:  J W Fabre; P J Morris
Journal:  Transplantation       Date:  1972-11       Impact factor: 4.939

3.  Planned preimmunization of renal allograft recipients.

Authors:  W T Newton; C B Anderson
Journal:  Surgery       Date:  1973-09       Impact factor: 3.982

4.  Specific inhibition of organ allograft rejection by donor blood.

Authors:  R L Marquet; G A Heystek; W J Tinbergen
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

5.  Improved patient survival in renal transplantation.

Authors:  O Salvatierra; D Potter; K C Cochrum; W J Amend; R Duca; B L Sachs; R W Johnson; F O Belzer
Journal:  Surgery       Date:  1976-02       Impact factor: 3.982

6.  Prolongation effect of blood transfusions on kidney graft survival.

Authors:  G Opelz; P I Terasaki
Journal:  Transplantation       Date:  1976-10       Impact factor: 4.939

7.  HLA typing and primary cadaver graft survival.

Authors:  O Salvatierra; H A Perkins; K C Cochrum; R M Duca; D E Potter; W J Amend; N J Feduska
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

8.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

9.  Correlation between MLC stimulation and graft survival in living related and cadaver transplants.

Authors:  K C Cochrum; O Salvatierra; F O Belzer
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

10.  Association between treatment-resistant kidney-allograft rejection and post-transplant appearance of antibodies to donor B-lymphocyte alloantigens.

Authors:  J P Soulillou; M A Peyrat; J Guenel
Journal:  Lancet       Date:  1978-02-18       Impact factor: 79.321

View more
  38 in total

Review 1.  Balance Between the Proinflammatory and Anti-Inflammatory Immune Responses with Blood Transfusion in Sepsis.

Authors:  Teresa C Rice; Amanda M Pugh; Charles C Caldwell; Barbara St Pierre Schneider
Journal:  Crit Care Nurs Clin North Am       Date:  2017-06-23       Impact factor: 1.326

2.  Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation.

Authors:  Sherrie J Divito; Zhiliang Wang; William J Shufesky; Quan Liu; Olga A Tkacheva; Angela Montecalvo; Geza Erdos; Adriana T Larregina; Adrian E Morelli
Journal:  Blood       Date:  2010-06-24       Impact factor: 22.113

3.  Transfusion support of the transplant patient.

Authors:  E Nisbet-Brown
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

Review 4.  The lost chord: microchimerism and allograft survival.

Authors:  T E Starzl; A J Demetris; N Murase; M Trucco; A W Thomson; A S Rao
Journal:  Immunol Today       Date:  1996-12

Review 5.  Chimerism after organ transplantation.

Authors:  T E Starzl; A J Demetris; N Murase; M Trucco; A W Thomson; A S Rao; J J Fung
Journal:  Curr Opin Nephrol Hypertens       Date:  1997-05       Impact factor: 2.894

Review 6.  Pediatric kidney transplantation: a historical review.

Authors:  Priya S Verghese
Journal:  Pediatr Res       Date:  2016-10-12       Impact factor: 3.756

Review 7.  Transfusion-associated microchimerism: the hybrid within.

Authors:  Evan M Bloch; Rachael P Jackman; Tzong-Hae Lee; Michael P Busch
Journal:  Transfus Med Rev       Date:  2012-10-24

8.  Transplants from living donors in the United Kingdom and Ireland: a centre survey.

Authors:  P K Donnelly; D G Clayton; A R Simpson
Journal:  BMJ       Date:  1989-02-25

Review 9.  Identification and therapeutic management of highly sensitized patients undergoing renal transplantation.

Authors:  Lu Huber; Nils Lachmann; Michael Dürr; Mareen Matz; Lutz Liefeldt; Hans-H Neumayer; Constanze Schönemann; Klemens Budde
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

Review 10.  Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells.

Authors:  Adrian E Morelli; Adriana T Larregina
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.